Playing away from home
When it comes to showing off non-domestic operations, piquing the interest of your average analyst can be like trying to amuse...
Read more
Sell side Archive
Surprise,surprise
Seattle-based biotech PathoGenesis was riding high on tobramycin. Trade-named Tobi, it was a promising, easy-to-use new form of...
Read more
They might be giants
When Monaco Coach Corporation went public in 1993, the management team was fully prepared for the challenges small-cap companies...
Read more
Calling a sell a sell
In April I checked the analysts' recommendations as tabulated online. In the real world, if you see something, or someone,...
Read more
Language lesson: valuation
Investment advice has never been a scarce commodity, although sifting through the advice is not easy. Occasionally, one may...
Read more
Falling down
Investment analysts tend to be optimistic by nature. And anyway, it is easy to churn out glowing reports during ebullient times...
Read more
All the dish
To all the hard-working IROs who propped up Wall Street while the rest were frolicking at Niri's annual conference last month...
Read more
Roundtable: Investment pros on IR
DAVID SMITH, portfolio manager on the small cap growth team at Loomis Sayles & Co ($62 bn under management), was formerly a...
Read more
Changing course
A funny thing happened to Bob Gallant on his way to work one day last January. Just several days into his new job as investor...
Read more
Tipping the Balance
Hard as it may sometimes be to comprehend, one thing remains certain: analysts are human. They are not the calmly scientific...
Read more
